Astellas Pharma Inc (TSE:4503)
円 2,295.5 +62 (+2.78%) Market Cap: 4.11 Tn Enterprise Value: 4.39 Tn PE Ratio: 14.15 PB Ratio: 2.24 GF Score: 82/100

Q3 2024 Astellas Pharma Inc Earnings Presentation Transcript

Feb 05, 2024 / NTS GMT
Release Date Price: 円1700 (+1.19%)

Feb 05, 2024 / NTS GMT
Presentation
Feb 05, 2024 / NTS GMT

=====================
Corporate Participants
=====================
* Atsushi Kitamura
Astellas Pharma Inc. - CFO
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroyuki Matsubara
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Kasumi Haruta
UBS Investment Bank, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Koichi Mamegano
BofA Securities, Research Division - Analyst
* Miki Sogi
Sanford C. Bernstein

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot